| Literature DB >> 32197069 |
Carissa Dege1, Katherine H Fegan2, J Philip Creamer1, Melissa M Berrien-Elliott3, Stephanie A Luff1, Darren Kim1, Julia A Wagner3, Paul D Kingsley2, Kathleen E McGrath2, Todd A Fehniger3, James Palis4, Christopher M Sturgeon5.
Abstract
Natural killer (NK) cells are a critical component of the innate immune system. However, their ontogenic origin has remained unclear. Here, we report that NK cell potential first arises from Hoxaneg/low Kit+CD41+CD16/32+ hematopoietic-stem-cell (HSC)-independent erythro-myeloid progenitors (EMPs) present in the murine yolk sac. EMP-derived NK cells and primary fetal NK cells, unlike their adult counterparts, exhibit robust degranulation in response to stimulation. Parallel studies using human pluripotent stem cells (hPSCs) revealed that HOXAneg/low CD34+ progenitors give rise to NK cells that, similar to murine EMP-derived NK cells, harbor a potent cytotoxic degranulation bias. In contrast, hPSC-derived HOXA+ CD34+ progenitors, as well as human cord blood CD34+ cells, give rise to NK cells that exhibit an attenuated degranulation response but robustly produce inflammatory cytokines. Collectively, our studies identify an extra-embryonic origin of potently cytotoxic NK cells, suggesting that ontogenic origin is a relevant factor in designing hPSC-derived adoptive immunotherapies.Entities:
Keywords: EMP; HSC-independent; adoptive immunotherapy; definitive hematopoiesis; erythro-myeloid progenitor; human pluripotent stem cells; natural killer cells; ontogeny; primitive hematopoiesis; yolk sac
Mesh:
Year: 2020 PMID: 32197069 PMCID: PMC7185477 DOI: 10.1016/j.devcel.2020.02.016
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270